Most Recent
Samsung Bioepis sues Fresenius Kabi over patent for generic Humira
Intellectual Property 2022-08-04 11:12 pm By Sam Matthews

Samsung Bioepis Australia has sued fellow biotechnology company Fresenius Kabi over a biosimilar of top selling immunosuppressant drug Humira, saying the invention ā€˜does not achieve the promiseā€™ of a better formulation using fewer ingredients.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Drug companies drop bid for ACCC approval of Revlimid patent settlement
Competition & Consumer Protection 2022-07-29 11:44 am By Cat Fredenburgh

Bristol-Myers Squibb unit Celgene and two generic drug makers have withdrawn an application for ACCC approval of a patent settlement that would have allowed for an early launch of a generic version of blockbuster cancer drug Revlimid.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Kmart settles Jellycat lawsuit over knockoff ‘Bashful Bunny’
Intellectual Property 2022-07-25 2:55 pm By Christine Caulfield

Kmart Australia has resolved a case brought by UK-based Jellycat that accused the retailer of selling knockoffs of the plush toy designer’s signature ‘Bashful Bunny’.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

No whey: IP Australia sides with Fonterra in rejecting protein patent
Intellectual Property 2022-07-21 9:13 pm By Sam Matthews

IP Australia has rejected the patent application of Scandinavian dairy giant Arla Foods amba, finding its high-protein whey-based yoghurt invention lacked an inventive step.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Epoch Capital accuses analyst of taking confidential info
Intellectual Property 2022-07-20 11:56 pm By Cindy Cameronne

Trading firm Epoch Capital has brought proceedings against a quantitative analyst who allegedly downloaded confidential information from the firmā€™s computers.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Redbubble found liable again for infringing Hells Angels trade marks
Intellectual Property 2022-07-19 11:08 pm By Christine Caulfield

T-shirts and face masks sold on Redbubble violate Hells Angels’ trademarks, a judge has found, banning the online marketplace from further sales of infringing products and awarding damages to the motorcycle group.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

New laws needed to protect Indigenous cultural IP: report
Intellectual Property 2022-07-19 4:38 pm By Cindy Cameronne

The Productivity Commission has called for new laws that would allow traditional owners to take legal action when their cultural property is used without permission in the $250 million Aboriginal arts and crafts industry.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Bayer wants to amend Xarelto patent at centre of Sandoz’s invalidity claim
Intellectual Property 2022-07-15 11:37 am By Christine Caulfield

German pharmaceutical giant Bayer, which is facing a legal bid by generic drug maker Sandoz to invalidate patents covering blood clot drug Xarelto, is seeking to amend one of the patents in dispute.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Reflex fails to prove invalidity of Globaltech patent for devices sold to Boart Longyear
Intellectual Property 2022-07-14 2:03 pm By Cindy Cameronne

Technology company Reflex Instruments has lost its challenge to rival Globaltechā€™s patent for two mining survey tools, with a judge finding Reflex had not established the technology wasn’t novel and lacked an inventive step.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Orica lights match in fight with Dyno Nobel over explosives patents
Intellectual Property 2022-07-11 7:22 pm By Cat Fredenburgh

Explosives manufacturer Orica is closer to taking Dyno Nobel to court for allegedly infringing three of its explosives patents, filing proceedings to get more information about its rival’s CyberDet wireless detonator device.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?